108 related articles for article (PubMed ID: 1569569)
1. Inhibition of beta-lactamase by clavulanate. Trapped intermediates in cryocrystallographic studies.
Chen CC; Herzberg O
J Mol Biol; 1992 Apr; 224(4):1103-13. PubMed ID: 1569569
[TBL] [Abstract][Full Text] [Related]
2. Refined crystal structure of beta-lactamase from Staphylococcus aureus PC1 at 2.0 A resolution.
Herzberg O
J Mol Biol; 1991 Feb; 217(4):701-19. PubMed ID: 2005620
[TBL] [Abstract][Full Text] [Related]
3. Structure of a phosphonate-inhibited beta-lactamase. An analog of the tetrahedral transition state/intermediate of beta-lactam hydrolysis.
Chen CC; Rahil J; Pratt RF; Herzberg O
J Mol Biol; 1993 Nov; 234(1):165-78. PubMed ID: 8230196
[TBL] [Abstract][Full Text] [Related]
4. Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates.
Totir MA; Padayatti PS; Helfand MS; Carey MP; Bonomo RA; Carey PR; van den Akker F
Biochemistry; 2006 Oct; 45(39):11895-904. PubMed ID: 17002290
[TBL] [Abstract][Full Text] [Related]
5. Structures of the acyl-enzyme complexes of the Staphylococcus aureus beta-lactamase mutant Glu166Asp:Asn170Gln with benzylpenicillin and cephaloridine.
Chen CC; Herzberg O
Biochemistry; 2001 Feb; 40(8):2351-8. PubMed ID: 11327855
[TBL] [Abstract][Full Text] [Related]
6. Clavulanate inactivation of Staphylococcus aureus beta-lactamase.
Rizwi I; Tan AK; Fink AL; Virden R
Biochem J; 1989 Feb; 258(1):205-9. PubMed ID: 2494991
[TBL] [Abstract][Full Text] [Related]
7. The beta-lactamase stability of amoxycillin with the beta-lactamase inhibitor, clavulanic acid.
Reading C; Farmer T; Cole M
J Antimicrob Chemother; 1983 Jan; 11(1):27-32. PubMed ID: 6600741
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of TEM-2 beta-lactamase from Escherichia coli by clavulanic acid: observation of intermediates by electrospray ionization mass spectrometry.
Brown RP; Aplin RT; Schofield CJ
Biochemistry; 1996 Sep; 35(38):12421-32. PubMed ID: 8823177
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the SHV-1 beta-lactamase by sulfones: crystallographic observation of two reaction intermediates with tazobactam.
Kuzin AP; Nukaga M; Nukaga Y; Hujer A; Bonomo RA; Knox JR
Biochemistry; 2001 Feb; 40(6):1861-6. PubMed ID: 11327849
[TBL] [Abstract][Full Text] [Related]
10. Raman crystallographic studies of the intermediates formed by Ser130Gly SHV, a beta-lactamase that confers resistance to clinical inhibitors.
Helfand MS; Taracila MA; Totir MA; Bonomo RA; Buynak JD; van den Akker F; Carey PR
Biochemistry; 2007 Jul; 46(29):8689-99. PubMed ID: 17595114
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the IMP-1 metallo beta-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor.
Concha NO; Janson CA; Rowling P; Pearson S; Cheever CA; Clarke BP; Lewis C; Galleni M; Frère JM; Payne DJ; Bateson JH; Abdel-Meguid SS
Biochemistry; 2000 Apr; 39(15):4288-98. PubMed ID: 10757977
[TBL] [Abstract][Full Text] [Related]
12. Novel fragments of clavulanate observed in the structure of the class A β-lactamase from Bacillus licheniformis BS3.
Power P; Mercuri P; Herman R; Kerff F; Gutkind G; Dive G; Galleni M; Charlier P; Sauvage E
J Antimicrob Chemother; 2012 Oct; 67(10):2379-87. PubMed ID: 22773738
[TBL] [Abstract][Full Text] [Related]
13. Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam.
Chin NX; McElrath MJ; Neu HC
Chemotherapy; 1988; 34(4):318-25. PubMed ID: 2850139
[TBL] [Abstract][Full Text] [Related]
14. Structure and kinetics of the beta-lactamase mutants S70A and K73H from Staphylococcus aureus PC1.
Chen CC; Smith TJ; Kapadia G; Wäsch S; Zawadzke LE; Coulson A; Herzberg O
Biochemistry; 1996 Sep; 35(38):12251-8. PubMed ID: 8823158
[TBL] [Abstract][Full Text] [Related]
15. Inhibitor-resistant class A beta-lactamases: consequences of the Ser130-to-Gly mutation seen in Apo and tazobactam structures of the SHV-1 variant.
Sun T; Bethel CR; Bonomo RA; Knox JR
Biochemistry; 2004 Nov; 43(44):14111-7. PubMed ID: 15518561
[TBL] [Abstract][Full Text] [Related]
16. X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid.
Swarén P; Golemi D; Cabantous S; Bulychev A; Maveyraud L; Mobashery S; Samama JP
Biochemistry; 1999 Jul; 38(30):9570-6. PubMed ID: 10423234
[TBL] [Abstract][Full Text] [Related]
17. Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfone.
Padayatti PS; Sheri A; Totir MA; Helfand MS; Carey MP; Anderson VE; Carey PR; Bethel CR; Bonomo RA; Buynak JD; van den Akker F
J Am Chem Soc; 2006 Oct; 128(40):13235-42. PubMed ID: 17017804
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the inactivation of the P54 mutant of beta-lactamase from Staphylococcus aureus PC1.
Herzberg O; Kapadia G; Blanco B; Smith TS; Coulson A
Biochemistry; 1991 Oct; 30(39):9503-9. PubMed ID: 1892849
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the thiol RTEM-1 beta-lactamase by 6-beta-bromopenicillanic acid. Identity of the primary active-site nucleophile.
Knap AK; Pratt RF
Biochem J; 1987 Oct; 247(1):29-33. PubMed ID: 2825657
[TBL] [Abstract][Full Text] [Related]
20. Crystallographic structure of a phosphonate derivative of the Enterobacter cloacae P99 cephalosporinase: mechanistic interpretation of a beta-lactamase transition-state analog.
Lobkovsky E; Billings EM; Moews PC; Rahil J; Pratt RF; Knox JR
Biochemistry; 1994 Jun; 33(22):6762-72. PubMed ID: 8204611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
